Laurus Labs Ltd

  • BSE Code : 540222
  • NSE Symbol : LAURUSLABS
  • ISIN : INE947Q01028
  • Industry :PHARMACEUTICALS - INDIAN - BULK DRUGS & FORMLN

up-arrow 849.35 -25.00(-2.86%)

Open Price ()

874.30

Prev. Close ()

874.35

Volume (No’s)

2,233,515

Market Cap ()

45,850.03

Low Price ()

846.00

High Price ()

874.95

 

Board Meetings

Start Date End Date Purpose
09-Jul-2025 25-Jul-2025 Quarterly Results Please see attached Please see annexed Please see annexed (As Per BSE Announcement Dated on :25.07.2025)
15-May-2025 15-May-2025 Please see annexed enclosure.
10-Apr-2025 24-Apr-2025 Laurus Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/04/2025 inter alia to consider and approve the audited financial results of the Company for the quarter and year ended March 31 2025 and payment of 2nd Interim Dividend for FY 2024-25 and fixation of record date for determining the eligibility of shareholders if approved. Board Meeting Outcome for Board Meeting Outcome - 24.04.2025 The Board of Directors approved the payment of 2nd Interim Dividend of Rs.0.80/- (40%) per equity share of Rs.2/- each, for the Financial Year 2024-25. Further, pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements), 2015, the Company has fixed 'May 09, 2025' as the 'Record Date' for determining the eligibility of the Shareholders. The Dividend amount will be paid on or after May 20, 2025. (As Per BSE Announcement Dated on 24.04.2025)
06-Jan-2025 24-Jan-2025 Laurus Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/01/2025 inter alia to consider and approve the un-audited Financial Results of the Company for the quarter and nine months ended December 31 2024. Please see annexed enclosure. (As Per BSE Announcement Dated on: 24/01/2025)
17-Oct-2024 24-Oct-2024 Laurus Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/10/2024 inter alia to consider and approve We hereby inform you that a meeting of the Board of Directors of the Company will be held on Thursday October 24 2024 inter-alia: a) to consider and approve the Un-audited Financial Results of the Company for the quarter and half year ended September 30 2024; b) to consider the proposal for payment of Interim Dividend for FY 2024-25 and fixation of record date for determining the eligibility of shareholders if approved. Results - Half Year Ended September 30, 2024 Interim Dividend FY 2024-25 (As Per BSE Announcement Dated on: 24/10/2024)

Copyright © 2024 Arihant Capital Markets Ltd. All rights Reserved.

Designed,Developed and Content powered by CMOTS Infotech (ISO 9001:2015 certified)

x
  • QR-CodeNew